Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Pediatric Blood & Cancer|March 7, 2025
Impact of Invasive Fungal Diseases on Treatment Outcomes in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: Insights From a Single-Center StudyAmrutha Narayana Murthy, Shyam Srinivasan, Vasundhara Patil, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 14, 2020
Insulinization in T2DM with Basal Analogues During COVID-19 Pandemic: Expert Opinion from an Indian PanelManoj Chawla, Sunil M Jain, Jothydev Kesavadev, et al.
Psycho-Oncology|August 26, 2021
Psychological distress in primary caregivers of children with cancer during COVID-19 pandemic-A single tertiary care center experienceBadira Cheriyalinkal Parambil, Savita Goswami, Nirmalya Roy Moulik, et al.
Pediatric Blood & Cancer|November 19, 2022
Pediatric cancer-associated thrombosis: Analysis from a tertiary care cancer center in IndiaNidhi Dhariwal, Venkata Rama Mohan Gollamudi, K P Sangeetha, et al.
American Journal of Hematology|November 21, 2024
Treatment-Free Remissions in Children With Chronic Myeloid Leukemia (CML): A Prospective Study From the Tata Memorial Hospital (TMH) Pediatric CML (pCML) CohortNirmalya Roy Moulik, Swaminathan Keerthivasagam, Gaurav Chatterjee, et al.
Annals of Hematology|July 21, 2023
Treating relapsed B cell-precursor ALL in children with a setting-adapted mitoxantrone-based intensive chemotherapy protocol (TMH rALL-18 PROTOCOL) - experience from Tata Memorial Hospital, IndiaNirmalya Roy Moulik, Swaminathan Keerthivasagam, Swetha V Velagala, et al.
British Journal of Haematology|December 15, 2023
Treatment and follow-up of children with chronic myeloid leukaemia in chronic phase (CML-CP) in the tyrosine kinase inhibitor (TKI) era-Two decades of experience from the Tata Memorial Hospital paediatric CML (pCML) cohortNirmalya Roy Moulik, Swaminathan Keerthivasagam, Ankita Pandey, et al.
JCO Global Oncology|February 29, 2024
Epilepsia Partialis Continua as a Sequelae of Measles Infection in Children With Hematolymphoid MalignanciesSudivya Sharma, Chetan Dhamne, Shilpushp Bhosale, et al.
European Journal of Haematology|September 14, 2023
15-color highly sensitive flow cytometry assay for post anti-CD19 targeted therapy (anti-CD19-CAR-T and blinatumomab) measurable residual disease assessment in B-lymphoblastic leukemia/lymphoma: Real-world applicability and challengesGaurav Chatterjee, Priyanka Dhende, Simpy Raj, et al.
Leukemia & Lymphoma|August 8, 2020
Machine learning derived genomics driven prognostication for acute myeloid leukemia with <i>RUNX1-RUNX1T1</i>Anam Fatima Shaikh, Chinmayee Kakirde, Chetan Dhamne, et al.
Pageof 7